Search research articles
Contact Us
Filters
Showing results (81-90 of 154) with videos related to
Page
of 16
Sort By:
Cancer
|
September 19, 2002
Characterization of 11 human sarcoma cell strains: evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors
Mei Hu, Garth L Nicolson, Jonathan C Trent, et al.
World Journal of Clinical Oncology
|
December 18, 2015
Fluoxetine induces cytotoxic endoplasmic reticulum stress and autophagy in triple negative breast cancer
Michelle Bowie, Patrick Pilie, Julia Wulfkuhle, et al.
Cancer Cell
|
November 16, 2004
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Yan M Li, Yong Pan, Yongkun Wei, et al.
Molecular Cell
|
June 7, 2002
Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis
Ming Tan, Tong Jing, Keng-Hsueh Lan, et al.
Oncogene
|
June 26, 2021
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer
Yufan Qiu, Yi Yang, Riyao Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance
Jing Lu, Ming Tan, Wen-Chien Huang, et al.
Science Signaling
|
July 31, 2014
MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer
Umadevi Thirumurthi, Jia Shen, Weiya Xia, et al.
Cancer Research
|
May 28, 2009
Breast cancer metastasis: challenges and opportunities
Jing Lu, Patricia S Steeg, Janet E Price, et al.
Cancer Research
|
July 10, 2012
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer
Qingfei Wang, Shau-Hsuan Li, Hai Wang, et al.
Molecular Cancer Therapeutics
|
May 22, 2007
Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation
Jonathan A F Hannay, Juehui Liu, Quan-Sheng Zhu, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 154) with videos related to
Sort By:
Page
of 16
Cancer
|
September 19, 2002
Characterization of 11 human sarcoma cell strains: evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors
Mei Hu, Garth L Nicolson, Jonathan C Trent, et al.
World Journal of Clinical Oncology
|
December 18, 2015
Fluoxetine induces cytotoxic endoplasmic reticulum stress and autophagy in triple negative breast cancer
Michelle Bowie, Patrick Pilie, Julia Wulfkuhle, et al.
Cancer Cell
|
November 16, 2004
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Yan M Li, Yong Pan, Yongkun Wei, et al.
Molecular Cell
|
June 7, 2002
Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis
Ming Tan, Tong Jing, Keng-Hsueh Lan, et al.
Oncogene
|
June 26, 2021
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer
Yufan Qiu, Yi Yang, Riyao Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance
Jing Lu, Ming Tan, Wen-Chien Huang, et al.
Science Signaling
|
July 31, 2014
MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer
Umadevi Thirumurthi, Jia Shen, Weiya Xia, et al.
Cancer Research
|
May 28, 2009
Breast cancer metastasis: challenges and opportunities
Jing Lu, Patricia S Steeg, Janet E Price, et al.
Cancer Research
|
July 10, 2012
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer
Qingfei Wang, Shau-Hsuan Li, Hai Wang, et al.
Molecular Cancer Therapeutics
|
May 22, 2007
Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation
Jonathan A F Hannay, Juehui Liu, Quan-Sheng Zhu, et al.
Page
of 16